-
Jun 17, 2023
Empowering the Next Generation of Innovators
Sep 27, 2022
Sunovion Scientists Receive Recognition for Innovation at International Society for CNS Clinical Trials and Methodology (ISCTM) Meeting
Jul 18, 2022
Taking on the future of medicine and mental health
Apr 15, 2022
Sunovion and the Boston Red Sox Supports the Next Generation of Innovators
Dec 09, 2021
Long-term Results of TAAR1 Agonist Ulotaront Published in NPJ Schizophrenia
Dec 01, 2021
Understanding Trace Amine-Associated Receptor 1 – A Novel Target In the Treatment of Schizophrenia
Apr 01, 2021
James Rawls, Global Head of Regulatory Affairs Shares Insights with Future Life Sciences Leaders
Feb 11, 2021
Award-Winning Animated Video Brings STEM Careers to Life
Oct 26, 2020
Sunovion Profile in The Boston Globe Reinforces CNS Leadership During 10th Anniversary Year
Apr 15, 2020
Experimental Schizophrenia Drug Could Reduce Long-Neglected Symptoms
